Tagged fda-commissioner

Dr. Rajamannan Holds Meeting With CDRH Ombudsman Abiy Desta to Review New Evidence of Concealment and Injuries Related to the Testing of FDA Investigational Heart Device
Press Release

Dr. Rajamannan Holds Meeting With CDRH Ombudsman Abiy Desta to Review New Evidence of Concealment and Injuries Related to the Testing of FDA Investigational Heart Device

"Our responsibility is to do no harm and to protect from harm," says Dr. Rajamannan.

 Read More
Dr. Rajamannan Replies to FDA's Demands of New Evidence Surrounding Harm to Patients in an Open Letter to Members of Congress, the FDA Commissioner Hahn and HHS Secretary Azar and the CDC and the World Health Organization
Press Release

Dr. Rajamannan Replies to FDA's Demands of New Evidence Surrounding Harm to Patients in an Open Letter to Members of Congress, the FDA Commissioner Hahn and HHS Secretary Azar and the CDC and the World Health Organization

An Open Letter to The Who/CDC/FDA/HHS/Congress Regarding Faulty Heart Devices

 Read More
Dr. Rajamannan Replies to FDA's Demands of New Evidence Surrounding Harm to Patients in an Open Letter to Members of Congress, the FDA Commissioner Hahn and HHS Secretary Azar
Press Release

Dr. Rajamannan Replies to FDA's Demands of New Evidence Surrounding Harm to Patients in an Open Letter to Members of Congress, the FDA Commissioner Hahn and HHS Secretary Azar

An Open Letter to the FDA/HHS/Congress Regarding Faulty Heart Devices

 Read More
Dr. Rajamannan Sends Over to the FDA Commissioner the US Senate Finance Investigation Files to Help the FDA's Review of Newly Discovered Design Control Study in Chicago
Press Release

Dr. Rajamannan Sends Over to the FDA Commissioner the US Senate Finance Investigation Files to Help the FDA's Review of Newly Discovered Design Control Study in Chicago

Minneapolis FDA delays reporting to the patients in Chicago the non-exempt testing of the device affecting 667 patients

 Read More
Dr. Rajamannan Sends Over to the Illinois Department of Public Health Safety Concerns in Chicago Regarding FDA's Affidavit as Published in the Daily Northwestern in 2019
Press Release

Dr. Rajamannan Sends Over to the Illinois Department of Public Health Safety Concerns in Chicago Regarding FDA's Affidavit as Published in the Daily Northwestern in 2019

Minneapolis FDA delays reporting to the patients in Chicago the non-exempt testing of the device affecting 667 patients

 Read More
Newly Minted FDA Commissioner Dr. Stephen Hahn Receives Minneapolis FDA Affidavit From Dr. Nalini Rajamannan Regarding FDA Design Control Study Using a Non-Exempt Medical Device
Press Release

Newly Minted FDA Commissioner Dr. Stephen Hahn Receives Minneapolis FDA Affidavit From Dr. Nalini Rajamannan Regarding FDA Design Control Study Using a Non-Exempt Medical Device

Minneapolis FDA confirms no plan to inform patients of non-exempt medical devices placed in 667 citizens

 Read More